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ABSTRACT Ia molecules play a key role in antigen rec-
ognition by T lymphocytes. To analyze the structural features
of the individual a and 1a chains relevant to the assembly of
intact Ia molecules, mouse fibroblasts were cotransfected with
various combinations of haplotype- and isotype-mismatched la
a//3 gene pairs. Two important points emerged. First, the level
of surface expression of a given haplotype-mismatched AaAp
pair appears to depend upon the a and P chain alleles involved.
Second, transfection with some isotype-mismatched combina-
tions such as Ed.A results in a significant level of surface
expression of a stable mixed-isotype dimer, which also appears
to be normally expressed at a low level by an lad-positive B
lymphoma. Moreover, a T-cell hybridoma specific for human
gamma globulin and restricted by the Ed molecule was found
to be efficiently stimulated by theEdA -positive transfectant in
the presence of antigen. The stimulation was specifically
inhibited by monoclonal antibodies directed to either the Ia or
the L3T4 molecule. These findings suggest that the estimates of
the potential number of Ia molecules available in an animal for
restricting T-lymphocyte recognition of antigens must be
revised.
The I region of the mouse major histocompatibility complex
encodes four polypeptide chains which are denoted A,, Ap,
Ea,, and Ep and are involved in the control of immune
responsiveness (1). Both a and f chains may be divided into
two extracellular regions of approximately 90 residues each,
a transmembrane region of about 30 residues, and a cyto-
plasmic tail of about 15 residues. The Aa and Ap chains
associate noncovalently inside the cell as one isotypic
heterodimer, the I-A molecule, which is then transported to
the cell surface. Similarly, the Ea chain combines noncova-
lently with the E, chain to give rise to a second cell-surface
isotype, the I-E molecule (2). Association between the a and
,B chains is apparently required for the expression of either at
the cell surface (3). The expression of a homodimer such as
EaEa or of mixed-isotype dimers (e.g., AaEp or EaA,3) have
not been described to date. This suggests that the assembly
ofan isotype-matched a/,f chain dimer is controlled by amino
acid residues that are conserved in each chain within an
isotype (4). In accordance with this hypothesis, analysis of
I-region-heterozygous animals has revealed the existence of
"hybrid" (transcomplementing) Ia molecules, resulting from
the combinatorial association between isotype-matched a
and Ai chains (5, 6). For instance, in (H-2b x H-2") F1 mice,
comparable amounts ofAbAl and AIAb dimers are expressed
on the cell surface in addition to the parental A AA and AaAO
molecules. However, reports of widely differing concentra-
tions of different AaA# or EaE# complexes in cells from some
I-region heterozygotes (7-9) suggest that polymorphic resi-
dues present on the first domain of a/fl chains may also
contribute to dimer formation.
Recent studies have shown that L cells transfected with
isotype- and haplotype-matched pairs of a/fl chain genes can
express the corresponding Ia (I region-associated) molecules
on the cell surface (reviewed in ref. 10). The ability to express
unique combinations of Ia genes in isolation after transfer
into mouse L cells offers the opportunity to analyze the
precise rules controlling the pairing of a/,8 polypeptide
chains. In this report, we examine this question directly by
transfecting L cells with haplotype-mismatched and isotype-
mismatched pairs ofgenes. Although L cells expressing A'A'
molecules were readily detected, surface expression of the
reciprocal combination AkAd was not observed. Unexpect-
edly, transfection of L cells with the isotype-mismatched
EdAd gene pair resulted in the cell surface expression of a
mixed-isotype Ia dimer. That this molecule was nevertheless
functional was seen by the ability of this EdAd -expressing
L-cell transfectant to present the antigen human gamma
globulin (HGG) to an HGG-specific and I-Ed-restricted T-
lymphocyte hybridoma. The earlier estimates generally as-
sumed the existence only of intraisotypic a/fl combinatorial
association. Our results suggest that the potential number of
Ia-restricting elements available in an animal may be larger
than these estimates. This may be beneficial to the animal, as
it has been suggested that combinatorial association expands
the immunologic response capacities of I region-heterozy-
gous animals over those of homozygous animals (11-13).
Thus, our data suggest that the Ia-molecule repertoire size
may be even larger and more accurately estimated, at least
for some haplotype combinations (e.g., H-2d x H-2'9, as the
total number of compatible intra and interisotype a/fl chain
associations.
MATERIALS AND METHODS
Mice. All strains, the origin of which have been described
(14), were maintained in our animal facilities.
Cell Lines. The AODH7.1 T-lymphocyte hybridoma was
kindly provided by P. Marrack (15). It originates from DBA/2
mice and produces interleukin 2 (IL-2) when stimulated with
the antigen HGG in the presence of I-Ed-positive antigen-
presenting cells. The IL-2-dependent cytotoxic T lympho-
cyte L cell line was maintained as described (16). M12.4.1
and A20-2J AGR are two Iad-positive B-cell lymphomas (17,
48).
Transfected Fibroblast Cell Lines. The transfectants were
generated by cotransfer of the genes of Ia subunits (6 ,ug each)
and thymidine kinase (100 ng) into the mouse Ltk- cell line
(18). The selection of clones CA14.11.14 (AkAk), CA36.3.2(E*E9), and CA36.1.3 (E PEX') has been described (18, 19).
The CA42.13.10 L-cell transfectant clone expresses the Ad
chain in combination with the Ed chain. Plasmid pCA52
Abbreviations: HGG: human gamma globulin; IL-2: interleukin 2.
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containing the entire Al gene from BALB/c liver DNA was
constructed by inserting into pSV2gpt a 9-kilobase EcoRI-
BamHI fragment obtained by partial digestion of cosmid H-2d
34.2 (20). Plasmid pCA66 containing the complete Eda gene
was constructed by inserting into pUC9 a 6.5-kilobase
HindIII fragment from cosmid H-2d 17.2 (20). The Ad gene
used in construction of CA29.5.2 and CA34.9.5 L-cell
transfectants was derived as described by Norcross et al.
(21). The CA45.6.7 and CA45.8.9 L-cell transfectants ex-
press hybrid Ep chain in combination with Ek (unpublisheddata).
Monoclonal Antibodies. Fig. 1 Left summarizes the main
characteristics of the different anti-Ia monoclonal antibodies
used in this study (14, 22, 23). Antibodies MKD6 (24) and
17/227 (25) were kindly provided by P. Marrack and G.
Hammerling, respectively. Antibodies 34.5.3S (26), 14.4.4S
(27), and 10.2.16 (28) were obtained from the American Type
Culture Collection Distribution Center. H129-326 is a rat
anti-T200 monoclonal antibody and H129-19 is a rat anti-L3T4
monoclonal antibody (16).
Radioimmunoassay. Two-step radioimmunoassay of cell-
surface Ia molecules were performed as described (14). The
presence of a stable EdA dimer in the CA42.13.10 L-cell
transfectants was assessed by using a two-site "sandwich"
immunoassay (29). For this purpose, anti-Ia monoclonal
antibodies were diluted in 10 mM phosphate-buffered saline
(pH 7.4) to a concentration of 40,ug/ml and were used to coat
the wells ofpolyvinyl microtiter plates by passive adsorption.
Unbound monoclonal antibodies were washed out, and the
remaining solid-phase binding sites were saturated with
bovine serum albumin. Cells to be analyzed were lysed with
0.5% Nonidet P-40/1% bovine serum albumin/0.1 mM
phenylmethylsulphonyl fluoride/0.02% sodium azide in
phosphate-buffered saline. After 15 min at 0°C and centrifu-
gation at 100,000 x g for 1 hr, 50 ,1u of the cell lysate was
applied to each antibody-coated well for 1 hr. After the
unbound antigens were washed out, the wells were incubated
at 4°C overnight with the '25I-labeled 81C monoclonal anti-
body (5 x 105 cpm per well). Finally, unbound radiolabeled
probe was washed off, and the radioactivity associated with
the solid phase was measured.
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FIG. 1. Serological analysis of EdAl molecules present on the
surface of the L-cell transfectant CA42.13.10 with 3.3 Ug of each of
the purified monoclonal antibodies per ml. Cell-bound antibodies
were detected with '25I-labeled protein A (1251-protein A). The values
obtained with monoclonal antibodies 10.2.16, 9A, 39G, 40K, and 74D
represent background binding. The Kk-specific monoclonal antibody
was used as a positive control.
Antigen-Presentation Assay. Microcultures in 96-well tissue
culture plates were prepared containing 1 x 105 AODH7.1
hybridoma T cells, 1 x 105 antigen-presenting cells, and 250
,ug of HGG (Sigma) per ml in a total volume of 250 ,1..
Stimulation of AODH7.1 was assessed by estimating the
amount of IL-2 present in a 24-hr supernatant as described
(24).
RESULTS
Cotransfer of the Ed and A4d Genes Results in the Surface
Expression of a Mixed-Isotype Ia Molecule. Mouse L-cell
fibroblasts were transfected with various combinations of
a/P chain gene pairs. Surface expression of the resulting Ia
molecules was monitored by using 10.2.16, an A4k chain-
specific monoclonal antibody (30); MKD6, an anti-I-Ad
monoclonal antibody; and 81C, an anti-I-Ek monoclonal
antibody recognizing an epitope analogous to the Ea chain-
determined specificity Ia.7. The transfectants CA14.11.14,
CA29.5.2, and CA36.2.1, which received isotype- and
haplotype-matched a/,B chain genes, expressed the corre-
sponding Ia molecules at a high level (18, 19,21) (Fig. 2). Note
that sequence comparisons have revealed that the Eda and Ek
genes are identical; therefore, Ed and Ek are synonymous
alleles. CA34.9.5 cells express a low but detectable level of
the haplotype-mismatched AdAk dimer. However, we were
unable to detect an AaAp complex at the surface ofCA34.11.1
cells despite the presence of normal levels of Ak and 4
mRNA transcripts (data not shown). This lack of expression
of the AkAp molecule was further confirmed by our inability
to detect the chain-determined specificities with several
monoclonal antibodies (31-33). Similarly, cotransfer of the
Ed and A genes did not result in the expression of a
detectable La molecule (clone CA42.12.5). However, cotrans-
fection of the Ea and A genes led to the unexpected
expression of an 81C- and MKD6-positive Ia molecule on the
surface of the CA42.13.10 transfectant. It should be noted
that L cells transfected with the Eadf or the Al chain gene alone
showed no staining above background with antibodies 81C or
MKD6, respectively (data not shown). These results allow us
to draw two major conclusions. First, intraisotypic a/, chain
free assembly is not a universal property of Ta molecules; its
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FIG. 2. Analysis of the Ia molecules present at the surface of
L-cell transfectant cloned lines. Cells (5 x 10) were incubated with
1:3 serial dilutions of the indicated monoclonal antibodies. Cell-
bound antibodies were detected by using 1251I-labeled protein A
(1251I-protein A). Results represent the mean of three experiments.
The Kk-specific monoclonal antibody was used as a positive control.
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occurrence depends both on the haplotype and on the a/B
chain pair under consideration. Second, at least one combi-
nation ofisotype-mismatched chains can result in the surface
expression of an interisotypic Ia molecule, the properties of
which were analyzed in detail in the following experiments.
Serological Analysis of the EAO Molecule-Expressing L
Cells. Three monoclonal antibodies raised against (MKD6
and 34.5.3S) or cross-reactive with (17/227) the I-Ad mole-
cule demonstrated significant binding to the CA42.13.10
transfectant. However, analysis of the full titration curves of
these antibodies with CA42.13.10 cells (Fig. 2; data not
shown) indicates that they gave a reproducibly weaker
binding relative to the antibodies reacting with the epitopes
designated as "cluster I" of the I-E molecule (see below).
Thus, the Ad chain-determined epitopes recognized by these
antibodies seem to be partially affected by the nature of the
a-chain isotype. Twenty monoclonal antibodies raised
against the I-Ek molecule and cross-reactive with the I-Ed
molecule were subsequently analyzed for their ability to bind
the expressed EdaAd molecule. As summarized in Fig. 1, these
antibodies define three clusters of topologically distinct
epitopes on the I-E molecule (12, 14). "Cluster I" antibodies
reacted strongly with EaAo-expressing CA42.13.10 cells.
These data formally demonstrate that the specificity of
cluster I antibodies is primarily determined by the nonpoly-
morphic Ea chain irrespective of the isotype of the associated
,X chain. None of the I-Ed cross-reactive "cluster II" anti-
bodies (74C, 97D, 97J) reacted with CA42.13.10 cells. There-
fore, it appears that the epitopes recognized by this set of
antibodies are dependent upon the interaction between
isotype-matched chains. Finally, analysis of the I-Ed cross-
reactive "cluster III" antibodies with CA42. 13.10 cells
divides them into a negative group (39D, 9A, 39G, 40K) and
a positive group (40B, 82B, 74A, 9B, 82C). Interestingly,
most of the antibodies pertaining to this latter group cross-
react with strains that do not express the I-E molecule
(C57BL/10, B1O.GD, BlO.M, or D2.GD) and therefore
recognize determinants also present on the I-A", I-A , I-A ,
and I-Ad molecules (Fig. 1). Subsequent analysis of one of
these antibodies (40B) indicates that it recognizes the I-A and
I-E isotypes in both the k and d haplotypes equally well (23).
The present results extend the distribution of this highly
conserved epitope to the mixed isotype E.Ap molecule.
The above studies do not, however, prove the existence of
stable EaAs dimers in CA42.13.10 cells. To formally dem-
onstrate this point, we have used a two-site sandwich
immunoassay (29) that specifically detects the EaAs dimers
present both at the cell surface and in the cytoplasm. A crude
cell lysate was prepared, and the Ia molecules containing the
Ad chain were specifically immobilized with monoclonal
antibodies such as MKD6, 34.5.3S, or 17/227 (see above). A
second 251I-labeled monoclonal antibody (81C) directed
against an Ea chain-determined epitope was then used to
detect putative EdAd dimers. Such an analysis of the
CA42.13.10 L-cell transfectants unequivocally demonstrated
the presence of stable EaAs dimers (Table 1). Analysis of an
EkaEdp-positive transfectant (CA36.2.1) confirmed the speci-
ficity of this assay and prompted us to examine the Iad_
positive B lymphoma A20.2J AGR for the presence of EdAd
dimers. A20.2J AGR cells appear to express a low but
significant level of mixed-isotype dimer. However, in such
cells competition between Ad and Ed for Ed may favor
intraisotype pairing (Table 1).
A T-Lymphocyte Hybridoma Uses the E?!Ad Molecule as a
Restriction Element. The functional relevance of the EaAOdimer was analyzed by using a panel of 11 T-cell hybridomas
specific for the copolymer (Glu-Ala-Tyr), and restricted by
the I-Ad molecule. None of these hybridomas was able to use
the EdA dimer as a restricting element (date not shown).
However, another T-cell hybridoma, AODH7. 1, specific for
HGG and restricted by the I-Ed molecule, was found to be
efficiently stimulated by the EdaAd-positive transfectant in the
presence of HGG (Table 2). Analysis of the la specificity of
this hybridoma on a panel of L cells transfected with
"exon-shuffled" Ep chain genes assigns its reactivity to the
highly polymorphic first domain of the Ep chain (Table 2).
Therefore, regardless of the exact constitution 'of the Ia
restriction element recognized by the AODH7.1 cells, at least
a portion must be formed by sequence shared between the
first polymorphic domains of the Ed and Ad chains. The
generality of this observation remains to be determined.
Further evidence for the direct involvement of the EdaAO
dimer in the antigen presentation function was obtained by
using monoclonal anti-Ia antibodies to inhibit this function.
Activation of the AODH7.1 T-cell hybridoma, induced by
HGG, in the presence of either the CA42.13.10 transfectant
or an Iad-positive B lymphoma, could be inhibited by
antibodies directed toward the mixed-isotype dimer (e.g.,
81M and 81C in Table 3). Parenthetically, the antibodies
MKD6 and 34.5.3S, which are directed to the Ad molecule
and cross-react with the EdAd dimer, failed to inhibit the
activation ofAODH7. 1 when the CA42.13.10 cells were used
as APC (Table 3). This may be due to their relatively weak
binding to CA42.13.10 cells (Fig. 2) compared to the Ea-
reactive antibodies.
Finally, the anti-L3T4 monoclonal antibody H129-19 was a
potent inhibitor of antigen-induced activation ofAODH7.1 in
the presence ofE9A-positive L cells (Table 3). This suggests
that if L3T4 is an Ia-binding molecule (34, 35), its binding site
is still present on the mixed-isotype dimer.
Table 1. A two-site sandwich radioimmunoassay provides direct evidence for the existence of the
E~dXA dimer in transfectant CA42.13.10, transfectant CA36.2.1, and Iad-positive B-cell lymphoma
Binding of 'l25-labeled 81C antibody, cpm
Monoclonal antibody CA42.13.10 (EtA) CA36.2.1 (EdE5) A20.2J AGR (Ad, Ed)
fixed on wells 1 x 106 cells 1 x 106 cells 3 x 106 cells 1 x 106 cells
81C (Ek, cluster I) 995 1,313 1,910 888
74A (Ek, cluster III) 34,335 68,335 57,654 32,310
MKD6 (Ad) 11,033 1,024 4,706 1,956
34.5.3S (Ad) 22,450 1,506 6,813 2,560
17/227 (Ak) 5,064 1,324 5,328 3,114
74C (Ek, cluster II) 1,064 22,666 27,543 150,683
97J (E , cluster II) 1,635 ND 17,812 7,007
Cell lysates obtained from CA42.13.10 (EtAd L-cell transfectants), CA36.2.1 (E~Ed L-cell transfect-
ants), or A20.2J AGR (Iad-expressing B-cell lymphoma) were analyzed by using the two-site sandwich
radioimmunoassay as described. Each well was incubated with 50 gl of cell lysate corresponding to the
equivalent of either 106 or 3 x 106 cells. Results are expressed in cpm and represent the mean of three
experiments. The specificity of the monoclonal antibodies has been described in Fig. 2.
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Table 2. Antigen-induced IL-2 response of hybrid AODH.7.1 in the presence of different
antigen-presenting cells (APC)
Ia expression
Transfected IL-2 production byTransfected
~~~~AODH7.1 in
E_ presence of
APC Eof L pi j32,TM,CY Endogenous Medium HGG
M12.4* None AdEd 1916 31,900
BALB/ct None Ad,Ed 2204 14,700
DBA/2t None AdEd 2516 29,754
D2.GDt None Ad 2132 2,124
CA36.1.3t k d k k None 2104 2,140
CA36.2.1t k d d d None 1988 24,012
CA45.6.7* k d d k None 2132 18,936
CA45.8.9t k d k d None 2656 2,488
CA42.13.10t EfA P None 1852 16,710
AODH7.1, an HGG-specific I-Ed-restricted T-cell hybridoma, was cultured with various APC in the
presence or absence of HGG. After 24 hr of culture, supernatants were assayed for the presence of IL-2
at a 1:6 dilution by the incorporation of [3H]thymidine by the IL-2-dependent cytotoxic T-cell L-cefl
line. The origin (domain) of the exons constituting the hybrid Ep genes used for transfection is indicated:
L, leader; TM, transmembrane; CY, cytoplasmic. The values represent the mean cpm of triplicate
culture wells.
*B-cell lymphoma line.
tSpleen cells.
*L-cell transfectants.
DISCUSSION
The generation of L-cell transfectants expressing various
combinations of haplotype- and isotype-mismatched Ia poly-
peptide chains leads to conclusions that contrast with those
previously derived from immunoprecipitation and two-dimen-
sional gel analysis. First, the level of surface expression of a
given haplotype-mismatched AaApA pair appears to depend on
the a and ,B chain alleles involved. For instance, AbA, AlA b
(12), and AdA molecules appear to constitute permissive
combinations, whereas A 1A molecule has in fact not been
detected (this paper; refs. 9 and 36). Second, transfection
with some isotype-mismatched combinations such as EdAd
results in significant surface expression of a stable mixed-
isotype dimer. The absence of surface expression of the E'Ak
combination supports the importance of allelic polymor-
phism in the first domains of the ,B subunits in control of a/,B
chain pairing. Furthermore, we have demonstrated that the
assembly of an EdA dimer also occurs normally in an Iad
B-cell lymphoma. However, in such cells, isotypically con-
served sequences appear to drive a/,B chain assembly pre-
Table 3. Ia and L3T4 molecules are involved in the recognition
of antigen by AODH7.1 T-cell hybridoma in presence of
antigen-presenting CA42.13.10 or M12.4.1 cells
[3H]Thymidine
incorporation per culture,
A cpm
CA42.13.10 M12.4.1
mAB Specificity (Etdi) (AdEd)
H129-326 T200 17,549 42,080
H129-19 L3T4 3,219 8,612
MKD6 Ad 17,053 12,069
34.5.3S Ad 16,533 41,200
81M I-Ek, cluster I 2,312 3,750
82C I-Ek, cluster III 1,908 8,541
Anti-Ia and anti-L3T4 monoclonal antibodies (mAbs) were ana-
lyzed for their ability to block antigen presentation by CA42.13.10 or
M12.4.1 cells. Culture conditions and assay for IL-2 production were
identical to those described in Table 2. Monoclonal antibodies were
included in the cultures at 20 ,g/ml. The nonblocking antibody
H129-326 was used as a negative control.
dominantly toward intraisotypic pairing. These observations
of interisotypic pairing are consistent with the recent results
of Maloy et al. (37), who reported the existence of mixed-
isotype Ia molecules in spleen cells of H-2d haplotype mice
by using a combination of sequential immunoprecipitation
and radiochemical amino acid sequencing. In addition, they
support the view that the genes encoding a and ,B chains of
the I-A and I-E isotypes have each evolved from a common
ancestral gene by duplication and diversification, while their
products still keep the potential (at least in one combination)
to assemble together. Our present results on surface expres-
sion of EaA13 dimers also suggest an alternative explanation
to the observations made with the I-region recombinant strain
A.TFR5. A.TFR5 cells do not synthesized an Ep chain but
react weakly with anti-Ia.7 (Ea) antiserum. These findings
have been interpreted in favor of the existence of free Ea
polypeptides at the cell surface (38, 39). However, in analogy
to the existence of the EaAp molecule, it is possible that theEkAf dimer is expressed at a low level at the cell surface in
this strain. The important point is that combinatorial asso-
ciation between allelic products of the same isotype (e.g.,
AAb) and between allelic products of different isotypes
(e.g., EaAP) may considerably expand the repertoire of Ia
molecules available both to homozygous and heterozygous
mice. This conclusion may have important implications for
the phenomena of immune responsiveness.
It is interesting to consider these observations with regard
to the existence of a putative "hot spot" for recombination
within the I region (40). As a result of its localization in the
intron between the ,B1 and 132 exons of the Ep gene (ref. 41;
and J. Kobori, E. Strauss, K. Minard, and L.H., unpublished
data), the polymorphic Ap and A:, genes appear to be inlinkage disequilibrium. Such a unique structural organization
may in fact be evolutionarily advantageous in preventing the
occurrence of recombinant haplotypes with nonpermissive
Aa and Ap alleles (e.g., AkWAd) and the subsequent generation
ofhomozygotes lacking a functional I-A molecule. Converse-
ly, the nonpolymorphic Ea chain appears to recombine more
or less independently of the polymorphic Ep1 region.
It should be emphasized that the occurrence of interiso-
typic pairing and of nonpermissive intraisotypic combina-
tions may have important implications for the understanding
of the associations existing between human Ia molecules
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(HLA-DP, -DQ, and -DR) and the susceptibility to certain
diseases. In this regard, the formation of trans-complement-
ing HLA-DQ molecules has been proposed recently as a
plausible explanation for the increased susceptibility of
HLA-DR3/4 heterozygotes to insulin-dependent diabetes
mellitus (42).
"Exon-shuffling" and haplotype-mismatched a//3 chain
gene pairing studies support the view that class I al and a2
and Ia al and 81 polymorphic domains interact tightly to
form unique quaternary structures recognized by T-cell
receptor molecules (10). For instance, T-cell clones restricted
by hybrid Ia molecules are not stimulated by the parental Ia
molecules and vice versa. In agreement with the above
observations, we have shown that the EaAP-positive L cells
were unable to activate antigen-specific T-cell hybridomas
restricted by the I-Ad molecule. However, AODH7.1 T-cell
hybridoma constitutes an exception to this rule, since
AODH7.1 is able to use both EdEd and EdaA molecules as a
restricting element. Note that the AODH7.1 normal T-cell
parent originated from a DBA/2 (H-2") animal, which leaves
open the possibility that it could have been originally acti-
vated by HGG in the context of either the EdEd or EdAd
molecules. Our findings parallel the recent observations of an
alloreactive T-cell clone that recognizes a determinant shared
by EkEb and AbA ml2 (43) and of bulk T-cell populations able
to recognize sheep insulin in the context of the A Axml2,
EkE , or EkE molecules (44). A more precise estimate of the
frequency of these T-cell clones directed to "public" Ia
determinants broadly shared by different alleles and genetic
subregions (45-47) must await limiting dilution analyses.
Finally, the functional studies of "hybrid" F1 determinants
(12) have suggested that the EIAg3 dimer may also encode
unique "interisotypic" determinants recognized by allo- or
self-restricted T cells.
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